Adamas Announces Proposed Public Offering of Common Stock

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. TMUS
9. SPY
10. SBUX

Go back to Adamas Announces Proposed Public Offering of Common Stock

Adamas Pharma (ADMS) Prices 2.5M Shares at $23

January 6, 2016 10:37 PM EST

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced the pricing of its underwritten public offering of 2,500,000 shares of its common stock at a price to the public of $23.00 per share. Adamas also granted the underwriters a 30-day option to acquire an additional 375,000 shares from... More

Adamas Pharma (ADMS) Announces Issuance of Markman Ruling in Namenda XR Suit

January 6, 2016 6:24 AM EST

Adamas Pharma (NASDAQ: ADMS) disclosed the following on Wednesday:

On January 5, 2016, the Delaware District Court issued a Markman ruling in the litigation that we, Forest Laboratories, Merz Pharma GmbH & Co. KGaA, and Merz Pharmaceuticals GmbH (together Merz) filed against several companies that submitted... More